Prothena Share Price

Prothena Share Price

NASDAQ: PRTA | Small Cap | Healthcare
$8.37
+$0.13 (1.58%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Prothena Stock Performance

Open
$8.40
Prev. Close
$8.23
Circuit Range
N/A
Day Range
$8.33 - $8.65
Year Range
$7.73 - $11.77
Volume
62,877
Average Traded
$8.46

Prothena Share Price Today

As of 19 November 2026, Prothena Corporation plc's share price is $8.37. The stock opened at $8.40, compared to its previous close of $8.23. During today's trading session, Prothena Corporation plc's share price traded between $8.33 and $8.65, with an average price of $8.49. Over the past 52 weeks, the stock has recorded a high of $11.77 and a low of $7.73. In terms of performance, Prothena Corporation plc's share price has declined by 17.67% over the last six months and is down 22.37% on a year-on-year basis.

Prothena Share Price Chart

Line chart of the Prothena price trend over the selected period. The price rose overall, ranging from 8.21 to 8.65, ending at 8.37.
$8.33$8.65
L
Show Current Price
H

Prothena Stock Fundamentals & Key Indicators

Market Cap
$450.28M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.47
Revenue (TTM)
$9.68B
Return On Equity (TTM)
-8.91%
Profit Margin
-2521.59%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
23.53%

Prothena Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.02$51.08$1.01$0.62
Net Profit-$21.59$32.72-$18.58-$16.51
Net Profit Margin-107950.00%64.06%-1839.60%-2662.90%
Income ChangeN/A251.55%-156.78%11.14%

Prothena Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$53.91$91.37$135.16$9.68
Net Profit-$116.95-$147.03-$122.31-$244.09
Net Profit Margin-216.94%-160.92%-90.49%-2521.59%
Income ChangeN/A-25.72%16.81%-99.57%

Prothena Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets11.6161.757.138.94
Current Assets315.19485.41639.28719.1
Total Assets326.8547.11696.38758.04
Non Current Liabilities5.4911.6878.1385.85
Current Liabilities40.8448.556.8950.15
Total Liabilities46.3360.18135.02135.99
Shareholders' Equity280.47486.93561.37622.04

Prothena Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-163.58-150.05-133.91-108.82
Investing-0.14-0.3-2.77-0.46
Financing-0.141.5545.1241.46

About Prothena

Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. Prothena is developing and applying its proprietary CYTOPE technology to target a broad spectrum of intracellular disease pathways in the brain and periphery. The company's pipeline includes both wholly-owned and partnered programs like Prasinezumab, Coramitug (PRX004), BMS-986446 (PRX005), PRX019, TDP-43 CYTOPE, and PRX012-TfR, being developed for the potential treatment of Parkinson's disease, ATTR amyloidosis with cardiomyopathy, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases.

Prothena Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$8.32
$8.38
-1.18%
Oct 2026
$8.56
$8.47
+0.89%
Sep 2026
$9.28
$8.40
-7.59%
Aug 2026
$8.05
$9.09
+12.10%
Jul 2026
$9.84
$8.11
-17.26%
Jun 2026
$9.90
$9.80
-3.54%
May 2026
$11.13
$10.16
-8.26%
Apr 2026
$10.01
$11.07
+14.06%
Mar 2026
$9.11
$9.71
+11.93%
Feb 2026
$8.72
$8.68
-1.48%
Jan 2026
$9.43
$8.80
-7.66%
Dec 2025
$11.10
$9.54
-11.51%

Prothena Share Price FAQs